TY - JOUR
T1 - Metagenomic profile of gut microbiota in children during cholera and recovery
AU - Monira, Shirajum
AU - Nakamura, Shota
AU - Gotoh, Kazuyoshi
AU - Izutsu, Kaori
AU - Watanabe, Haruo
AU - Alam, Nur Haque
AU - Nakaya, Takaaki
AU - Horii, Toshihiro
AU - Ali, Sk Imran
AU - Iida, Tetsuya
AU - Alam, Munirul
N1 - Funding Information:
This research was jointly supported by National Institutes of Health Grant No. RO1AI039129, under collaborative agreements between the Johns Hopkins Bloomberg School of Public Health, and the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), the National Institute of Infectious Diseases (NIID), Japan, and a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports Culture and Technology, Japan (MEXT), the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases by the MEXT and the project for the International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University from the MEXT. ICDDR,B acknowledges with gratitude the commitment of NIH, NIID and MEXT, Japan to the Center’s research efforts. Additional support came to the icddr,b that provides unrestricted funds including the governments of Bangladesh, Canada, the United Kingdom, Sweden, and Australia.
PY - 2013
Y1 - 2013
N2 - Background: The diverse bacterial communities colonizing the gut (gastrointestinal tract) of infants as commensal flora, which play an important role in nutrient absorption and determining the state of health, are known to alter due to diarrhea. Method. Bacterial community dynamics in children suffering from cholera and during recovery period were examined in the present study by employing metagenomic tool, followed by DNA sequencing and analysis. For this, bacterial community DNA was extracted from fecal samples of nine clinically confirmed cholera children (age 2-3 years) at day 0 (acute cholera), day 2 (antibiotic therapy), day 7 and, and day 28, and the variable region of 16S rRNA genes were amplified by universal primer PCR. Results: 454 parallel sequencing of the amplified DNA followed by similarity search of the sequenced data against an rRNA database allowed us to identify V. cholerae, the cause of cholera, in all nine children at day 0, and as predominant species in six children, accounting for 35% of the total gut microbiota on an average in all the nine children. The relative abundance (mean ± sem %) of bacteria belonging to phyla Proteobacteria, Firmicutes, Bacteroidetes, and Actinobacteria, was 55 ± 7, 18 ± 4, 13 ± 4, and 8 ± 4, respectively, at day 0, while these values were 12 ± 4, 43 ± 4, 33 ± 3, and 12 ± 2, respectively, at day 28. As antibiotic therapy began, V. cholerae count declined significantly (p< 0.001) and was found only in four children at day 2 and two children at day 7 with the relative abundance of 3.7% and 0.01%, respectively, which continued up to day 28 in the two children. Compared to acute cholera condition (day 0), the relative abundance of Escherichia coli, Enterococcus, and Veillonella increased at day 2 (antibiotic therapy) while Bifidobacterium, Bacteroides, and Ruminococcus decreased. Conclusion: Cholera results expulsion of major commensal bacteria of phyla Bacteroidetes, Firmicutes, and Actinobacteria, and increase of harmful Proteobacteria to colonize the gut during acute and convalescence states. The observed microbiota disruption might explain the prevalent malnutrition in children of Bangladesh where diarrheal diseases are endemic.
AB - Background: The diverse bacterial communities colonizing the gut (gastrointestinal tract) of infants as commensal flora, which play an important role in nutrient absorption and determining the state of health, are known to alter due to diarrhea. Method. Bacterial community dynamics in children suffering from cholera and during recovery period were examined in the present study by employing metagenomic tool, followed by DNA sequencing and analysis. For this, bacterial community DNA was extracted from fecal samples of nine clinically confirmed cholera children (age 2-3 years) at day 0 (acute cholera), day 2 (antibiotic therapy), day 7 and, and day 28, and the variable region of 16S rRNA genes were amplified by universal primer PCR. Results: 454 parallel sequencing of the amplified DNA followed by similarity search of the sequenced data against an rRNA database allowed us to identify V. cholerae, the cause of cholera, in all nine children at day 0, and as predominant species in six children, accounting for 35% of the total gut microbiota on an average in all the nine children. The relative abundance (mean ± sem %) of bacteria belonging to phyla Proteobacteria, Firmicutes, Bacteroidetes, and Actinobacteria, was 55 ± 7, 18 ± 4, 13 ± 4, and 8 ± 4, respectively, at day 0, while these values were 12 ± 4, 43 ± 4, 33 ± 3, and 12 ± 2, respectively, at day 28. As antibiotic therapy began, V. cholerae count declined significantly (p< 0.001) and was found only in four children at day 2 and two children at day 7 with the relative abundance of 3.7% and 0.01%, respectively, which continued up to day 28 in the two children. Compared to acute cholera condition (day 0), the relative abundance of Escherichia coli, Enterococcus, and Veillonella increased at day 2 (antibiotic therapy) while Bifidobacterium, Bacteroides, and Ruminococcus decreased. Conclusion: Cholera results expulsion of major commensal bacteria of phyla Bacteroidetes, Firmicutes, and Actinobacteria, and increase of harmful Proteobacteria to colonize the gut during acute and convalescence states. The observed microbiota disruption might explain the prevalent malnutrition in children of Bangladesh where diarrheal diseases are endemic.
KW - 16S rDNA
KW - Children
KW - Cholera
KW - Gut
KW - Microbiota
UR - http://www.scopus.com/inward/record.url?scp=84874066862&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84874066862&partnerID=8YFLogxK
U2 - 10.1186/1757-4749-5-1
DO - 10.1186/1757-4749-5-1
M3 - Article
C2 - 23369162
AN - SCOPUS:84874066862
SN - 1757-4749
VL - 5
JO - Gut Pathogens
JF - Gut Pathogens
IS - 1
M1 - 1
ER -